Results 81 to 90 of about 12,113 (164)

Enhancing anandamide signalling through fatty acid amide hydrolase inhibition: An update on the pharmacological strategy for treating psychiatric disorders. [PDF]

Transl Psychiatry
Couttas TA, Hoffmann AE, Jieu B, Golla FR, Shepherd CE, Leweke FM, Rohleder C.   +6 more
europepmc   +1 more source

A preliminary investigation of tobacco co-use on endocannabinoid activity in people with cannabis use. [PDF]

Drug Alcohol Depend Rep
Rabin RA, Farrugia J, Garani R, Mizrahi R, Rusjan P.   +4 more
europepmc   +1 more source

CYP46A1 activation by low-dose efavirenz uncovers the link between brain cholesterol metabolism, energetics, and vasculature. [PDF]

Biomed Pharmacother
Mast N, Bederman I, El-Darzi N, Pikuleva IA.   +3 more
europepmc   +1 more source

Anxiety level modulates endocrine and neuromodulatory responses to maximal exercise and 24-h recovery in elite rowers. [PDF]

Front Physiol
Ostapiuk-Karolczuk J, Dziewiecka H, Kasperska A, Cichoń-Woźniak J, Reysner M, Gruszka W, Basta P, Kaczmarczyk S, Skarpańska-Stejnborn A.   +8 more
europepmc   +1 more source

Circuit-Selective FAAH Inhibition Suppresses Experimental Absence Seizures. [PDF]

CNS Neurosci Ther
Morais TP, Bombardi C, Crunelli V, Di Giovanni G.   +3 more
europepmc   +1 more source

Selective Depletion of Gut Gram-Negative Bacteria Attenuates Alcohol Binge-Induced Cardiovascular Dysfunction by Lowering Cardiac Anandamide Levels. [PDF]

Am J Pathol
Cohen SE, Donovan ME, Gardner DJ, Sambo D, Karagoz SB, Cinar R, Goldman D, Gardner JD, Pacher P, Paloczi J.   +9 more
europepmc   +1 more source

Ex vivo stimulation of the trigeminal nucleus caudalis induces peripheral CGRP release in the trigeminal ganglion and reveals a distinct dopamine-endocannabinoid mechanism relevant to migraine. [PDF]

J Headache Pain
Christiansen IM, Reducha PV, Edvinsson L, Holm A, Haanes KA.   +4 more
europepmc   +1 more source

Molecular docking of danuglipron uncovers potential crossovers between GLP-1R and the endocannabinoid system. [PDF]

MicroPubl Biol
Dailey KA, Schneider LN, Petreaca RC, Yoder RJ.   +3 more
europepmc   +1 more source

Progressive endocannabinoid system dysregulation in autosomal dominant polycystic kidney disease. [PDF]

Mol Med
Betkar S, Nemirovski A, Ruppo S, Hinden L, Tam J.   +4 more
europepmc   +1 more source

Correction: Tetrahydrocannabinol and dopamine D1 receptor. [PDF]

Front Neurosci
Lee J.
europepmc   +1 more source